(firstQuint)Efficacy and Safety of Grass Pollen Sublingual Immunotherapy.

 Patients with seasonal grass pollen related rhinoconjunctivitis will be randomized to one of four treatment groups at 41 centres in Europe.

 Each treatment group will consist of approximately 150 patients and 150 patients will be randomized to a placebo group.

 The study will consist of a screening phase, a treatment phase and a variable maintenance period.

.

 Efficacy and Safety of Grass Pollen Sublingual Immunotherapy@highlight

The study is assessing efficacy and safety of three different dosage regimens of grass pollen sublingual immunotherapy in adult patients suffering from grass pollen related rhinoconjunctivitis.

